A myelosclerotic syndrome in mice engrafted with cells producing high levels of leukemia inhibitory factor (LIF).

DBA/2 mice engrafted with FDC-P1 cells producing high levels of the leukemia-inhibitory factor (LIF) developed high circulating levels of LIF and a fatal syndrome including the accumulation of excess osteoblasts in the marrow and new bone formation